theMednetRegister

Obstructive Lung Disease   

Questions discussed in this category

Will you incorporate ensifentrine in the treatment regimen of patients with COPD on baseline dual or triple inhaler therapy?
1 Answer available
Do you feel high dose Symbicort or Dulera is appropriate to use for SMART despite these doses not being studied in clinical trials?
1 Answer available
When would you recommend prescribing an asthmatic patient budesonide/salbutamol rather than budesonide/formoterol?
2 Answers available
What is your approach to de-escalation of asthma therapy if patients have remained clinically stable on triple inhaler therapy and a biologic agent?
1 Answer available
Is methacholine challenge on its way out?
1 Answer available
Is there a role for biologics to improve lung function in patients who have severe asthma with daily symptoms and reduced lung function but do not experience frequent exacerbations?
2 Answers available
How do you factor smoking history into biologic selection for asthma since the clinical trials generally excluded these patients?
1 Answer available
What factors do you consider prior to offering a trial of ICS/LABA therapy versus a methacholine challenge test in patients with suspected asthma but normal pulmonary function testing?
1 Answer available
Do you diagnose obstruction by the criteria of FEV1/FVC < 70% or < LLN?
5 Answers available
Do you use hypercapnia as an exclusion criteria in all patients that are being assessed for bronchoscopic lung volume reduction?
1 Answer available
What is your approach to inhaler therapy in a patient with asthma who cannot be on an inhaled corticosteroid due to ocular disease?
1 Answer available
What is your threshold to start triple therapy in mild to moderate asthma/COPD overlap with minimal functional limitation?
1 Answer available
What patient factors prompt you to consider starting dupilumab in patients with COPD?
Does active smoking status influence this decision?
2 Answers available
Will you use FeNO testing in all COPD patients to determine whether they are candidates for therapy with dupilumab?
If so, would this be a consideration in all patients regardless of active smoking status? FeNO in active smokers has been questioned, could this have ...
2 Answers available
Are the results of the BOREAS trial generalizable to non-white populations?
The cohort in the study was predominantly white. Do these results highlight significant disparities in COPD care?
2 Answers available
Did the low rate of COPD exacerbations in the BOREAS cohort overall confound the results of the study?
2 Answers available
Do you prescribe bronchodilators to patients with radiographic emphysema and respiratory symptoms, but no spirometric obstruction?
1 Answer available
Is there a role for biologics to help patients with ABPA who are steroid responsive and have removed their allergen insult, but continue to have an elevated serum IgE and incomplete resolution of symptoms return to their baseline functional status?
1 Answer available
Do you consider dual biologic therapy in patients with ABPA that remain steroid dependent despite the use of omalizumab?
2 Answers available
Is there a role for the use of biologics as steroid sparing agents in treating patients with ABPA who are intolerant to prednisone?
1 Answer available
Do you use continuous or intermittent bronchodilator therapy in severe airway obstruction?
1 Answer available
What is your second line therapy for patients with EGPA with mainly pulmonary and sinonasal features who did not respond to mepolizumab 300 mg/month and still require high doses of steroid?
2 Answers available
Are you using NAC in lieu of hypertonic saline amidst the current shortage of hypertonic saline in patients with either CF or non-CF bronchiectasis?
1 Answer available
How do you choose between azithromycin and roflumilast in the management of a patient with severe COPD who remains symptomatic with frequent exacerbations despite maximal dose LABA/LAMA/ICS with demonstrated compliance and proper inhaler technique?
1 Answer available
Are there any concerns utilizing apremilast for psoriatic arthritis in patients who are also taking roflumilast for COPD?
1 Answer available
Is there a role for biologic therapies in asthma-COPD overlap syndrome with evidence of type 2 inflammation?
2 Answers available
Do you find that complete interlobar fissures on HRCT correlate well with decreased collateral ventilation on endoscopic balloon occlusion in the evaluation and placement of endobronchial valves for bronchoscopic lung volume reduction?
2 Answers available
Do you consider bronchoscopic lung volume reduction in patients with homogenous emphysema?
1 Answer available


Papers discussed in this category

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000-04
Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.
Chest, 2018 Jan 11
A Randomized Trial of Itraconazole vs Prednisolone in Acute-Stage Allergic Bronchopulmonary Aspergillosis Complicating Asthma.
J Allergy Clin Immunol Pract, 2021 Mar 06
Real-World Effectiveness of Anti-IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal Sensitization.
Chest, 2020 Aug 31
Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma.
J Allergy Clin Immunol Pract, 2020 Jun 16
Omalizumab Is an Effective Intervention in Severe Asthma with Fungal Sensitization.
Cureus, 2020 Aug 12
Mepolizumab as Possible Treatment for Allergic Bronchopulmonary Aspergillosis: A Review of Eight Cases.
J Allergy Clin Immunol Pract, 2015 Jan 29
Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis.
American journal of respiratory and critical care medicine, 2013-04-01
Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health.
American journal of respiratory and critical care medicine, 2018-11-01
A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE).
Ann Am Thorac Soc,
The Clinical Significance of Collateral Ventilation.
Chest,
Rationale and design of The National Emphysema Treatment Trial: a prospective randomized trial of lung volume reduction surgery. The National Emphysema Treatment Trial Research Group.
Annals of the American Thoracic Society, 2015-05
The accuracy of computed tomography to predict completeness of pulmonary fissures. A prospective study.
Int J Chron Obstruct Pulmon Dis, 2020 Jun 09
An Integrative Approach of the Fissure Completeness Score and Chartis Assessment in Endobronchial Valve Treatment for Emphysema.
American journal of respiratory and critical care medicine, 2023 Aug 15
Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-controlled, Multicenter Phase III Trials (the ENHANCE Trials).

Related Topics

Copyright © 2024 theMednet
All Rights Reserved.